As of Oct 25
| +0.03 / +1.81%|
The 3 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a +77.51% increase from the last price of 1.69.
The current consensus among 3 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.